Riskpilot← Back to searchSign inGet full accessApoapsis Game Laboratories AB
ABActiveOrg 5591147466Skomakaregatan 6 (Apoapsis Game Laboratories Ab)Computer programming activities · NACE 6210Est. 201714 employees
Revenue 2025
SEK 10,7M
-34% vs 2024
EBITDA margin
-42.5%
-184% vs 2024
Equity ratio
31.5%
Financial strength
Net profit 2025
SEK -2,3M
-170% vs 2024
| Revenue | SEK 10,7M | -34% |
| EBITDA | SEK -4,5M | -184% |
| Net profit | SEK -2,3M | -170% |
| Total assets | SEK 3,4M | -66% |
| Equity | SEK 1,1M | -74% |
| Employees | 14 | — |
Legal name
Apoapsis Game Laboratories AB
Org number
5591147466
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
8 juni 2017
Share capital
SEK 51 300
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Verksamheten bedriver mjukvaruutveckling för datorspel.
Address
Skomakaregatan 6 (Apoapsis Game Laboratories Ab)
Email
contact@apoglabs.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 403 | 2 973 | 3 587 | 16 258 | 10 705 |
| Staff expenses | — | −1 771 | −2 804 | −7 408 | −9 722 |
| EBITDA | 767 | 510 | −393 | 5 399 | −4 548 |
| Depreciation & amort. | −0 | — | — | −5 | −13 |
| EBIT | 767 | 510 | −393 | 5 394 | −4 561 |
| Net financials | — | −1 | 4 | 23 | 90 |
| Profit before tax | 573 | 376 | 0 | 4 258 | −2 334 |
| Tax | −125 | −83 | −14 | −903 | — |
| Net profit | 448 | 293 | −14 | 3 355 | −2 334 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 912 | 2 518 | 2 199 | 10 070 | 3 411 |
| Equity | 1 365 | 973 | 772 | 4 127 | 1 073 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 312 | 178 | 449 | 3 806 | 2 339 |
| Total debt | 312 | 178 | 449 | 3 806 | 2 339 |
EBITDA margin
-42.5%
This company
15.8%
Market median
-369% vs market
20212025
Equity ratio
31.5%
This company
38.2%
Market median
+18% vs market
20212025
Return on equity
-217.5%
This company
18.4%
Market median
-1282% vs market
20212025
Net profit margin
-21.8%
This company
8.1%
Market median
-369% vs market
20212025
Asset turnover
3.14×
This company
1.12×
Market median
+180% vs market
20212025
Debt / equity
2.18×
This company
0.62×
Market median
-252% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UT Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Apoapsis Game Laboratories AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Urban Tor Erik Johansson | Chief Auditor | 0 companies |
| Olof Anders Kindblad | Board of Directors | 0 companies |
| Fredrik Olof Salomon | Chairman | 0 companies |
| Clara Viktoria Salomon | Deputy Board Member | 0 companies |
| Marie Anita Kindblad | Deputy Board Member | 0 companies |